688076 fundamentals
Key facts
Sinopep-Allsino Bio Pharmaceutical Co., Ltd. engages in the research and development, and manufactures of peptide drugs and small molecule drugs. Its products includes freeze-dried powder injections, small-volume injections, APIs, tablets, hard capsules, health products, and medical devices, research and development of pharmaceutical technology and biotechnology, production of pharmaceutical intermediates and peptide intermediates, production and sales of fine chemical products, self-operation and agency for various commodities and import and export business of technology, except for goods and technologies that are restricted by the state or prohibited from being imported. Sinopep Pharmaceutical, Inc. was founded on April 3, 2009 and is headquartered in Hangzhou, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company